Role of SOX10 Immunohistochemical Expression in Diagnosing Triple Negative Breast Cancer and Its Correlation With Clinicopathological Features

被引:1
|
作者
Tariq, Muhammad Usman [1 ]
Siddiqui, Muhammad Afnan [2 ]
Din, Nasir Ud [3 ]
Kayani, Naila [3 ]
机构
[1] Al Hada Armed Forces Hosp, Histopathol, Taif, Saudi Arabia
[2] Indus Hosp & Hlth Network, Histopathol, Karachi, Pakistan
[3] Aga Khan Univ Hosp, Pathol & Lab Med, Karachi, Pakistan
关键词
tumor infiltrating lymphocytes; immunohistochemistry; tnbc; triple negative breast cancer; sox10; MELANOCYTIC NEOPLASMS; CARCINOMA; FREQUENCY; UTILITY;
D O I
10.7759/cureus.59276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Triple -negative breast cancer (TNBC) poses a diagnostic challenge for histopathologists due to the reduced frequency of breast -specific markers. SOX10 has emerged as a useful diagnostic marker for TNBC. The aim of our study was to determine the frequency of SOX -10 immunohistochemical (IHC) expression in our cohort and assess its correlation with clinicopathological and histological features. Materials and methods: We included 72 primary TNBC cases. Specimens included tru-cut biopsies and excision specimens. We stained whole slide sections of these specimens with SOX10 antibody and calculated its frequency (%) of expression and H -score. We applied the chi-square test to assess the correlation between SOX10 expression and clinicopathological and histological features such as the patient's age, specimen type, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, tumor -infiltrating lymphocytes (TILs), necrosis, calcification, lymphovascular invasion (LVI), lymph node involvement, T stage, and N stage. Results: SOX10 expression was observed in 42 (58.3%) cases with a median H -score of 57.5. The expression was significantly higher in tru-cut biopsy specimens as compared to excision specimens (73.5 vs 41.7%) and TILs negative tumors as compared to TILs positive tumors (64.3% vs 27.3). Metaplastic carcinoma showed reduced expression when compared with non-metaplastic tumors (35.7% vs 63.8%), but statistical significance was not achieved. No correlation was observed with the patient's age, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, necrosis, calcification, LVI, lymph node involvement, T stage, and N stage. Conclusion: SOX10 was expressed in more than half of the TNBC cases of our study which not only highlights its diagnostic utility but advocated its application in combination with other breast -specific markers. The expression didn't correlate with the majority of clinicopathological and histological features, but correlation with tru-cut biopsy specimens and absence of TILs draws attention towards possible roles of proper fixation and host immunity, respectively.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy
    Mathur, Sandeep
    Johnson, Anjana
    Deo, S. V. S.
    Gogia, Ajay
    Kahol, Shruti
    Jain, Deepali
    Iyer, Venkateswaran
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 208 - 209
  • [32] The Diagnostic Utility of TRPS-1 and SOX10 in Triple-Negative Breast Cancers
    See, Sharlene
    Iwaz, Suzanne
    Zak, Taylor
    Laboy, Carissa
    Novo, Jorge
    Siziopikou, Kalliopi
    Blanco, Luis
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 191 - 192
  • [33] The Diagnostic Utility of TRPS-1 and SOX10 in Triple-Negative Breast Cancers
    See, Sharlene
    Iwaz, Suzanne
    Zak, Taylor
    Laboy, Carissa
    Novo, Jorge
    Siziopikou, Kalliopi
    Blanco, Luis
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 191 - 192
  • [34] Correlation of Cystatin E/M with Clinicopathological Features and Prognosis in Triple-Negative Breast Cancer
    Li, Quan
    Zheng, Zhou-Ci
    Ni, Chun-Jue
    Jin, Wen-Xu
    Jin, Yi-Xiang
    Chen, Yao
    Zhang, Xiao-Hua
    Chen, En-Dong
    Cai, Ye-Feng
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2018, 48 (01): : 40 - 44
  • [35] Nuclear Transcription Factor Sox10 Is Expressed in a Subset of Metastatic Triple Negative Breast Carcinomas
    Nelson, Emily
    Sharma, Rajni
    Argani, Pedram
    Cimino-Mathews, Ashley
    LABORATORY INVESTIGATION, 2015, 95 : 58A - 58A
  • [36] SOX10 Can Help Distinguish Triple Negative Breast Cancers from Gynecologic Carcinomas
    Rammal, Rayan
    Carter, Gloria
    Clark, Beth
    Elishaev, Esther
    Fine, Jeffrey
    Harinath, Lakshmi
    Jones, Mirka
    Soong, Thing Rinda
    Villatoro, Tatiana
    Yu, Jing
    Zhao, Chengquan
    Bhargava, Rohit
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 179 - 180
  • [37] SOX10 Can Help Distinguish Triple Negative Breast Cancers from Gynecologic Carcinomas
    Rammal, Rayan
    Carter, Gloria
    Clark, Beth
    Elishaev, Esther
    Fine, Jeffrey
    Harinath, Lakshmi
    Jones, Mirka
    Soong, Thing Rinda
    Villatoro, Tatiana
    Yu, Jing
    Zhao, Chengquan
    Bhargava, Rohit
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 179 - 180
  • [38] Nuclear Transcription Factor Sox10 Is Expressed in a Subset of Metastatic Triple Negative Breast Carcinomas
    Nelson, Emily
    Sharma, Rajni
    Argani, Pedram
    Cimino-Mathews, Ashley
    MODERN PATHOLOGY, 2015, 28 : 58A - 58A
  • [39] TRIPLE-NEGATIVE BREAST CANCER: CYTOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES
    Nakajima, H.
    Inoue, A.
    Fujita, M.
    Kawabata, K.
    ACTA CYTOLOGICA, 2010, 54 (03) : 437 - 437
  • [40] SOX10 is Frequently Expressed by Triple-Negative (Basal-Like) Breast Cancer: Diagnostic Pitfall and Opportunity
    Dhungana, Neha
    Thomason, Jon
    Chen, Stephanie
    Bellizzi, Andrew
    MODERN PATHOLOGY, 2018, 31 : 57 - 58